Sarecycline Exhibits Decreased Activity Against Representative Bacterial and Fungal Microflora Commonly Present in the Human Gastrointestinal Tract. J of Skin 2021, 5 (6), s83. https://doi.org/10.25251/skin.5.supp.83.